|
Originally published In Press as doi:10.1074/jbc.M502306200 on August 29, 2005
J. Biol. Chem., Vol. 280, Issue 44, 36609-36615, November 4, 2005
Role of Group A p21-activated Kinases in Activation of Extracellular-regulated Kinase by Growth Factors*
Alexander Beeser,
Zahara M. Jaffer,
Clemens Hofmann, and
Jonathan Chernoff1
From the
Tumor Cell Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111
The canonical extracellular-regulated kinase (ERK) signaling cascade, consisting of the Ras-Raf-Mek-ERK module, is critically important to many cellular functions. Although the general mechanism of activation of the ERK cascade is well established, additional noncanonical components greatly influence the activity of this pathway. Here, we focus on the group A p21-activated kinases (Paks), which have previously been implicated in regulating both c-Raf and Mek1 activity, by phosphorylating these proteins at Ser338 and Ser298, respectively. In NIH-3T3 cells, expression of an inhibitor of all three group A Paks reduced activation of ERK in response to platelet-derived growth factor (PDGF) but not to epidermal growth factor (EGF). Similar results were obtained in HeLa cells using small interference RNA-mediated simultaneous knockdown of both Pak1 and Pak2 to reduce group A Pak function. Inhibition of Pak kinase activity dramatically decreased phosphorylation of Mek1 at Ser298 in response to either PDGF or EGF, but this inhibition did not prevent Mek1 activation by EGF, suggesting that although Pak can phosphorylate Mek1 at Ser298, this event is not required for Mek1 activation by growth factors. Inhibition of Pak reduced the Ser338 phosphorylation of c-Raf in response to both PDGF and EGF; however, in the case of EGF, the reduction in Ser338 phosphorylation was not accompanied by a significant decrease in c-Raf activity. These findings suggest that Paks are required for the phosphorylation of c-Raf at Ser338 in response to either growth factor, but that the mechanisms by which EGF and PDGF activate c-Raf are fundamentally different.
Received for publication, March 1, 2005
, and in revised form, August 10, 2005.
* This work was supported by National Institutes of Health Grant GM54168 and CORE Grant CA-06927, American Cancer Society Grant CB-189, and an appropriation from the Commonwealth of Pennsylvania. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Tumor Cell Biology Program, Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111. Tel.: 215-728-5319; Fax: 215-728-3616; E-mail: J_Chernoff{at}fccc.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. S. McDaniel, J. D. Allen, S.-J. Park, Z. M Jaffer, E. G. Michels, S. J. Burgin, S. Chen, W. K. Bessler, C. Hofmann, D. A. Ingram, et al.
Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells
Blood,
December 1, 2008;
112(12):
4646 - 4654.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Soto, M. Yanagisawa, L. A. Marlow, J. A. Copland, E. A. Perez, and P. Z. Anastasiadis
p120 catenin induces opposing effects on tumor cell growth depending on E-cadherin expression
J. Cell Biol.,
November 18, 2008;
183(4):
737 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Smith, Z. M. Jaffer, J. Chernoff, and A. J. Ridley
PAK1-mediated activation of ERK1/2 regulates lamellipodial dynamics
J. Cell Sci.,
November 15, 2008;
121(22):
3729 - 3736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Zang, J. Gong, L. Luo, J. Zhou, X. Xiang, W. Huang, Q. Huang, X. Luo, M. Olbrot, Y. Peng, et al.
Characterization of Ser338 Phosphorylation for Raf-1 Activation
J. Biol. Chem.,
November 14, 2008;
283(46):
31429 - 31437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ammoun, C. Flaiz, N. Ristic, J. Schuldt, and C. O. Hanemann
Dissecting and Targeting the Growth Factor-Dependent and Growth Factor-Independent Extracellular Signal-Regulated Kinase Pathway in Human Schwannoma
Cancer Res.,
July 1, 2008;
68(13):
5236 - 5245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Katsube, T. Kato, M. Kitagawa, H. Noma, H. Fujita, and S. Kitagawa
Calpain-mediated regulation of the distinct signaling pathways and cell migration in human neutrophils
J. Leukoc. Biol.,
July 1, 2008;
84(1):
255 - 263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Zayed, W. Yuan, T. M. Leisner, D. Chalothorn, A. W. McFadden, M. D. Schaller, M. E. Hartnett, J. E. Faber, and L. V. Parise
CIB1 Regulates Endothelial Cells and Ischemia-Induced Pathological and Adaptive Angiogenesis
Circ. Res.,
November 26, 2007;
101(11):
1185 - 1193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Friedland, J. N. Lakins, M. G. Kazanietz, J. Chernoff, D. Boettiger, and V. M. Weaver
{alpha}6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-{kappa}B-dependent resistance to apoptosis in 3D mammary acini
J. Cell Sci.,
October 15, 2007;
120(20):
3700 - 3712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hybiske and R. S. Stephens
Mechanisms of Chlamydia trachomatis Entry into Nonphagocytic Cells
Infect. Immun.,
August 1, 2007;
75(8):
3925 - 3934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stockton, J. Reutershan, D. Scott, J. Sanders, K. Ley, and M. A. Schwartz
Induction of Vascular Permeability: betaPIX and GIT1 Scaffold the Activation of Extracellular Signal-regulated Kinase by PAK
Mol. Biol. Cell,
June 1, 2007;
18(6):
2346 - 2355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. E. E. Rennefahrt, S. W. Deacon, S. A. Parker, K. Devarajan, A. Beeser, J. Chernoff, S. Knapp, B. E. Turk, and J. R. Peterson
Specificity Profiling of Pak Kinases Allows Identification of Novel Phosphorylation Sites
J. Biol. Chem.,
May 25, 2007;
282(21):
15667 - 15678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, S.-J. Ding, W. Wang, J. M. Jacobs, W.-J. Qian, R. J. Moore, F. Yang, D. G. Camp II, R. D. Smith, and R. L. Klemke
Profiling signaling polarity in chemotactic cells
PNAS,
May 15, 2007;
104(20):
8328 - 8333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Suzuki, M. C. Wilkes, N. Garamszegi, M. Edens, and E. B. Leof
Transforming Growth Factor {beta} Signaling via Ras in Mesenchymal Cells Requires p21-Activated Kinase 2 for Extracellular Signal-Regulated Kinase-Dependent Transcriptional Responses
Cancer Res.,
April 15, 2007;
67(8):
3673 - 3682.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Morrison, T. Sperka, J. Manent, M. Giovannini, H. Ponta, and P. Herrlich
Merlin/Neurofibromatosis Type 2 Suppresses Growth by Inhibiting the Activation of Ras and Rac
Cancer Res.,
January 15, 2007;
67(2):
520 - 527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Guo, M. Debidda, L. Yang, D. A. Williams, and Y. Zheng
Genetic Deletion of Rac1 GTPase Reveals Its Critical Role in Actin Stress Fiber Formation and Focal Adhesion Complex Assembly
J. Biol. Chem.,
July 7, 2006;
281(27):
18652 - 18659.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|